GB2440332A - Polymer-metal complexes - Google Patents
Polymer-metal complexes Download PDFInfo
- Publication number
- GB2440332A GB2440332A GB0614613A GB0614613A GB2440332A GB 2440332 A GB2440332 A GB 2440332A GB 0614613 A GB0614613 A GB 0614613A GB 0614613 A GB0614613 A GB 0614613A GB 2440332 A GB2440332 A GB 2440332A
- Authority
- GB
- United Kingdom
- Prior art keywords
- polymer
- metal
- solution
- complex
- process according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229910052751 metal Inorganic materials 0.000 title claims abstract description 47
- 239000002184 metal Substances 0.000 title claims abstract description 47
- 239000000243 solution Substances 0.000 claims abstract description 98
- 229910021645 metal ion Inorganic materials 0.000 claims abstract description 74
- 238000000034 method Methods 0.000 claims abstract description 53
- 230000008569 process Effects 0.000 claims abstract description 49
- 150000003839 salts Chemical class 0.000 claims abstract description 48
- 229920000642 polymer Polymers 0.000 claims abstract description 45
- 229920001661 Chitosan Polymers 0.000 claims abstract description 38
- 239000007787 solid Substances 0.000 claims abstract description 33
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 28
- 229910052709 silver Inorganic materials 0.000 claims abstract description 25
- 239000004332 silver Substances 0.000 claims abstract description 25
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 19
- -1 polyvinylamine Polymers 0.000 claims abstract description 15
- NVXLIZQNSVLKPO-UHFFFAOYSA-N Glucosereductone Chemical compound O=CC(O)C=O NVXLIZQNSVLKPO-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000007790 solid phase Substances 0.000 claims abstract description 12
- 229920002101 Chitin Polymers 0.000 claims abstract description 11
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims abstract description 10
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 9
- 229920000615 alginic acid Polymers 0.000 claims abstract description 9
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 6
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910052802 copper Inorganic materials 0.000 claims abstract description 6
- 239000010949 copper Substances 0.000 claims abstract description 6
- 229910052718 tin Inorganic materials 0.000 claims abstract description 6
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229940072056 alginate Drugs 0.000 claims abstract description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229910052737 gold Inorganic materials 0.000 claims abstract description 5
- 239000010931 gold Substances 0.000 claims abstract description 5
- 229910052763 palladium Inorganic materials 0.000 claims abstract description 5
- 229910052697 platinum Inorganic materials 0.000 claims abstract description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims abstract description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims abstract description 4
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 4
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 53
- 235000010323 ascorbic acid Nutrition 0.000 claims description 25
- 239000011668 ascorbic acid Substances 0.000 claims description 25
- 229960005070 ascorbic acid Drugs 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 21
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 5
- 239000003349 gelling agent Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000011135 tin Chemical class 0.000 claims description 5
- 239000000783 alginic acid Substances 0.000 claims description 4
- 229960001126 alginic acid Drugs 0.000 claims description 4
- 150000004781 alginic acids Chemical class 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 150000007942 carboxylates Chemical class 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 2
- 125000000524 functional group Chemical group 0.000 claims description 2
- 150000003868 ammonium compounds Chemical class 0.000 claims 1
- 150000004696 coordination complex Chemical class 0.000 claims 1
- 239000000843 powder Substances 0.000 abstract description 19
- 239000012266 salt solution Substances 0.000 abstract description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical group [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 44
- 239000008367 deionised water Substances 0.000 description 36
- 238000006722 reduction reaction Methods 0.000 description 24
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 22
- 239000000725 suspension Substances 0.000 description 19
- 239000000047 product Substances 0.000 description 14
- 239000002245 particle Substances 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- 230000008033 biological extinction Effects 0.000 description 11
- 235000014655 lactic acid Nutrition 0.000 description 11
- 239000004310 lactic acid Substances 0.000 description 11
- 230000009467 reduction Effects 0.000 description 11
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 10
- 239000002244 precipitate Substances 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000012456 homogeneous solution Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 229920000307 polymer substrate Polymers 0.000 description 4
- 235000010378 sodium ascorbate Nutrition 0.000 description 4
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 4
- 229960005055 sodium ascorbate Drugs 0.000 description 4
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 241000220317 Rosa Species 0.000 description 3
- 108091006629 SLC13A2 Proteins 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 159000000007 calcium salts Chemical class 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- 241000238424 Crustacea Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 229920002873 Polyethylenimine Polymers 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 235000010376 calcium ascorbate Nutrition 0.000 description 2
- 229940047036 calcium ascorbate Drugs 0.000 description 2
- 239000011692 calcium ascorbate Substances 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000006196 deacetylation Effects 0.000 description 2
- 238000003381 deacetylation reaction Methods 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 2
- 239000011973 solid acid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- WTXXSZUATXIAJO-OWBHPGMISA-N (Z)-14-methylpentadec-2-enoic acid Chemical compound CC(CCCCCCCCCC\C=C/C(=O)O)C WTXXSZUATXIAJO-OWBHPGMISA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002083 enediols Chemical group 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000011133 lead Chemical class 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000007540 photo-reduction reaction Methods 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000003378 silver Chemical class 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000008259 solid foam Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
- A01N25/10—Macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
- C08B15/05—Derivatives containing elements other than carbon, hydrogen, oxygen, halogens or sulfur
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
- A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F26/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
- C08F26/02—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a single or double bond to nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/42—Introducing metal atoms or metal-containing groups
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Manufacture Of Metal Powder And Suspensions Thereof (AREA)
Abstract
A process for producing polymer-metal complexes comprises (i) contacting a metal salt solution with a polymer to form a polymer-metal ion complex, wherein the polymer and polymer-metal ion complex are in the solid phase, (ii) optionally dissolving the polymer-metal ion complex, and (iii) chemically reducing metal ions in the polymer-metal ion complex to form the polymer-metal complex. The solid phase comprises / 25 wt.% of the polymer and/or the polymer is in the form of a powder or flake. The polymer may be chitin, chitosan, alginate, polyvinylamine, carboxymethylcellulose, or hyaluronic acid. The metal salt may comprise silver, copper, gold, palladium, platinum, and/or tin. A polymer-metal complex in solution, which is translucent and free of suspended, particulate metal-containing species is also disclosed. A solid premix comprising a polymer-metal complex and a solid reducing agent and use of a reductone to reduce a polymer-metal ion complex to a polymer-metal complex are further claimed.
Description
<p>S</p>
<p>1 2440332</p>
<p>PROCESS</p>
<p>The present invention relates to a process for the production of a polymer-metal complex.</p>
<p>Combinations of certain metals with polymers have shown considerable potential for use as bioactive materials and/or for their catalytic applications. US 5817325 and US 5849311, for example, provide examples of antimicrobial articles, devices and formulations prepared by applying an organic coating to a substrate followed by immersing the coated substrate in a solution of silver or potassium salt.</p>
<p>However, in many of the polymer-metal combinations disclosed in the prior art, the metal is present in its ionic state as part of either an inorganic or an organic salt. The use of polymer-metal combinations in this form presents a number of problems, for example there is limited control over the release of the metal ions, which results in a rapid decrease in its effectiveness and, in the case of biomedical applications, there is the possibility of excess metal ions entering the body.</p>
<p>Further, in the case of silver, staining of the skin on contact with silver ions and a change in colour of the material due to gradual photoreduction of the silver ions are additional problems.</p>
<p>These problems have been overcome by reducing the metal ions to form polymer-metal complexes. In this respect several processes have been disclosed in the prior art, see, for example, JP 04 002877 and JP 03 045709, which describe the production of metal colloids by chemically reducing water-soluble salts of copper, lead, silver or tin in an aqueous solution containing a water-soluble polymer, or a mixture of watersoluble polymers thereof.</p>
<p>WO 00/492 19 discloses a process for treating a substrate to impart biocidal properties. The process comprises the steps of depositing or impregnating the substrate with solubilised chitosan, immersing the substrate in a solution of a silver salt and reducing the silver salt to atomic/metallic silver. Likewise, WO 02/15698 and EP-A-l3 12262 also describe the preparation of articles or powders, respectively, having contact biocidal properties.</p>
<p>There remains a need for improved processes for producing polymer-metal complexes and to improved polymer-metal complex products.</p>
<p>In a first aspect of the present invention, there is provided a process for producing a polymer-metal complex comprising the steps of: (i) contacting a solution comprising one or more metal salts with a polymer which is capable of interacting with the metal salt to form a polymer-metal ion complex and wherein the polymer and the polymer-metal ion complex are in the solid phase, said solid phase comprising the polymer in an amount of at least 25% by weight andlor being in the form of a powder or flake; (ii) optionally dissolving the polymer-metal ion complex; and (iii) chemically reducing metal ions in the polymer-metal ion complex to form the polymer-metal complex.</p>
<p>In a second aspect, the invention also provides the product obtainable by the process of the first aspect of the present invention.</p>
<p>In a third aspect, there is provided a polymer-metal complex in solution, which is translucent and free of suspended particulate metal-containing species. Thus, preferably, the solution contains no colloidal and/or suspended particles.</p>
<p>In a fourth aspect, there is provided a solid premix comprising a polymer-metal ion complex and a solid reducing agent.</p>
<p>In a fifth aspect, the invention provides a process for the production of a polymer-metal complex comprising the steps of: (a) contacting an aqueous solution comprising one or more metal salts with a solution comprising a]ginic acid or a salt thereof, polyvinylanune or a mixture thereof, (b) treating the solution in (a) with a gelling agent to form a gel; and (c) chemically reducing metal ions in the gel, wherein (b) and (c) may be carried out simultaneously or sequentially in any order.</p>
<p>in a sixth aspect, the invention provides the use of a reductone for reducing a polymer-metal ion complex to a polymer-metal complex.</p>
<p>The polymers useful in the process of the present invention, and which may be employed in step (1), preferably comprise functional groups selected from amine, carboxylic acid, carboxylate or hydroxyl, and mixtures thereof; and may be natural or synthetic polymers. For example, the polymer may be selected from the group consisting of chitin, chitosan and polyvinylamine, poly(ethylene imine), poly(lysine), cationic' polyacrylaniide copolymers, cellulose that has been denvatised to incorporate amine groups, alginate, hyaluronic acid, carboxymethyl cellulose, and polymers and copolymers containing acrylic acid and similar monomers. Most preferably, however, the polymer used in step (i) comprises amine functional groups and is selected from the group consisting of chitin, chitosan and polyvinylamine. Particularly preferred polymers are chitin and chitosan.</p>
<p>Chitin is a natural polymer found in the exoskeleton of crustaceans, the internal pen of squid, and the cell wall of a number of fungi. It is most commonly used after conversion to chitosan by a deacetylation treatment. Although chitosan may be obtained directly from certain fungi, almost all commercial chitosan is currently obtained from crustacean-derived chitin. However, chitin and chitosan from fungal sources are gradually becoming available in commercial quantities.</p>
<p>The teims chitin' and chitosan' do not refer to discrete and distinct polymers but to a range of structurally closely related polymers differing in the ratio of D-glucosamine and N-acetyl-D-glucosazmne residues. Chitins normally contain from 5-10% D-glucosainine residues and all chitosans, unless specially prepared by techniques involving multiple deacetylation processes, contain a proportion of N-acetyl-D-glucosamine residues.</p>
<p>The polymer used in step (i) of the process is a solid and is preferably in the form of a powder or flake. The solid phase typically comprises the polymer in an amount of at least 25%, preferably at least 30%, such as at least 40% or at least 50% by weight, more preferably at least 60% by weight, such as at least 70% or at least 80% or at least 90% by weight. The polymer is typically not in the form of a coating applied to a substrate.</p>
<p>S</p>
<p>The process steps (i), (ii) and (iii) may independently be carried out at any temperature, such as a temperature between room temperature and an elevated temperature (i.e., above room temperature) such as at a temperature of 25 to 95 C, more preferably at a temperature of 45 to 90 C, such as 60 to 90 C or 70 to 90 C, most preferably at a temperature of 80 to 90 C. Preferably, step (i) is carried out at elevated temperatures, as described above. Most preferably, step (i) is carried out at a temperature of 80 to 90 C and the subsequent steps (ii) and (iii) are carried out at room temperature. The term room temperature' as used herein has its ordinary meaning and typically ranges from 21 to 25 C. It has surprisingly been IS found that carrying out step (i) at elevated temperatures increases the stability of a subsequently formed solution of polymer-metal complex.</p>
<p>Without wishing to be bound by theory, it is believed that during step (i), metal ions in the solution are adsorbed, complexed or otherwise associated onto the polymer to form a polymer-metal ion complex. Typically, adsorption takes place at specific sites of the polymer substrate, for example, on the amine groups which may act as ligands and bind directly with the metal ions. Another suitable site for adsorption of the metal ions onto the polymers includes carboxylate groups, where the counter ion, which is usually a sodium, potassium or animoniuin ion, can be exchanged for the metal ions in solution. In this case, the binding may be through ionic/electrostatic forces or co-ordination bonds or a combination of these two mechanisms.</p>
<p>Step (i) is preferably performed to the stage of complete absorption, i.e., either when all of the metal ions in solution have been adsorbed onto the polymer or when the polymer is saturated and no more metal ions can be adsorbed. However, it will be appreciated that the rate of adsorption, and consequentially the time taken for complete adsorption, may vary depending on the temperature and other process variables used, such as the concentration of the metal salt solution.</p>
<p>Although the solution of one or more metal salts in step (i) can be of any concentration, higher concentrations are preferred.</p>
<p>If not all of the metal ions in solution have been adsorbed onto the polymer during step (i), the polymer-metal ion complex produced may be filtered off and subsequently washed to remove any excess metal salts. This may be carried out in the same solvent for the solution used in step (i), without the metal salts dissolved therein.</p>
<p>The amount, by weight of polymer, of metal ions that is preferably used in step (i) of the process ranges from 0.1 to 20 %, such as 1 to 20%, more preferably from 2 to 15 %, such as 2.5 to 10 %, most preferably from 3 to 8 %.</p>
<p>The one or more metal salts are preferably selected from the salts of silver, copper, gold, palladium, platinum and tin, and mixtures thereof. Silver salts are preferred.</p>
<p>Preferably, the one or more metal salts are present in an aqueous solution, in which case the metal salts must be water-soluble to some extent. Most preferably, the metal salt is silver nitrate. The term aqueous solution as used herein describes a solution in a solvent comprising at least 5%, such as at least 10%, preferably at least 25%, such as at least 50% or at least 75%, most preferably at least 95% such as at least 99% or even 100%, by weight of water.</p>
<p>In an alternative embodiment, the one or more metal salts may be present in a non-aqueous solution, such as a solution of the one or more metal salts in an anhydrous polar organic solvent e.g., a C1-C6 alcohol such as ethanol, methanol or isopropyl alcohol.</p>
<p>The polymer-metal ion complex formed in step (i) may be dissolved in step (ii), preferably at a pH below 6.5, before the metal ions are subjected to chemical reduction in step (iii). Suitable acids for carrying out step (ii) include but are not limited to organic acids, such as, for example, acetic acid, lactic acid, glutamic acid and glycolic acid.</p>
<p>Although, in one embodiment of the invention, step (i) is limited to contacting a solution comprising one or metals salts to a polymer wherein the polymer and the polymer-metal ion complex produced remain in the solid phase, it will be appreciated that the formation of polymer-metal ion complexes can also be achieved if the polymer is present as part of a solution in step (i). In this case, the resulting polymer-metal ion complex remains in solution and step (ii) of the process is made redundant.</p>
<p>Therefore, the present invention also contemplates a process for the production of a polymer-metal complex comprising the steps of: (I) contacting a solution comprising one or more metai salts with a polymer which is capable of interacting with the metal salt to form a polymer-metal ion complex and wherein the polymer and the polymer-metal ion complex are in solution; and (II) chemically reducing metal ions in the polymer-metal ion complex to form the polymer-metal complex.</p>
<p>Particularly preferred polymers for use in step (I) include water-soluble polymers, such as, for example, polyvinylamine, alginic acid or a salt thereof, carboxymethyl cellulose or a salt thereof, hyaluronic acid or a salt thereof, poly(ethylene imine) or mixtures thereof. However, polymer substrates which require a pH of below 6.5 in order to dissolve in the solution comprising one or metal salts in step (I) are also encompassed in this embodiment of the invention. A pH of below 6.5 may be achieved by the addition of, for example, an organic acid such as acetic acid, lactic acid, glutamic acid or glycolic acid.</p>
<p>Chemical reduction of the polymer-metal ion complex in the process of the invention may be camed out using any suitable reducing agent. Preferably, however, chemical reduction is carried out using a reductone, such as ascorbic acid or a salt thereof, which are more preferably non-toxic and readily available.</p>
<p>As used herein, the term reductone includes compounds containing an enediol structure stabilised by conjugation and hydrogen bonding with an adjacent group, RC(OH)C(OH)C(=O)R'. Preferably R and R' are the same or different and are selected from: hydroxyl; C1 to C20 alkyl, optionally substituted with C, to C3 alkyl, hydroxyl or C12 to C24 acyloxy; and R and R' may be linked to form a ring structure. Reductones are commonly derived from saccharides by oxidation at the carbon atom alpha to the carbonyl functionality. Ascorbic acid and its salts are the S preferred reductones, used alone or in combination. Suitable salts of ascorbic acid include food grade salts (such as, for example, sodium, potassium or calcium salts).</p>
<p>It will be appreciated that chemical reduction may be performed on polymer-metal ion complexes, which are either in the solid phase or in solution. For example, if the polymer-metal ion complex is in the solid phase (e.g., if step (ii) is omitted from the process), chemical reduction of metal ions may be carried out on the solid polymer-metal ion complex or the polymer-metal ion complex may be dissolved to form a solution prior to the step of chemical reduction.</p>
<p>Since ascorbic acid aids the dissolution of certain polymer substrates, such as chitosan., the use of ascorbic acid as the reducing agent may form part or all of the acid required to perform steps (ii) and (iii) of the process, simultaneously.</p>
<p>The molar ratio of reducing agent to metal ions in the polymer-metal ion complex in the chemical reduction step is preferably from 2:1 to 1:2.</p>
<p>During the chemical reduction step (i.e., step (iii) or step (II)), metal ions in the polymer-metal ion complex are reduced. Preferably, the metal ions are reduced to metallic atoms to form a polymer-metal complex. Preferably, the product of the chemical reduction step comprises more than 0.1% by weight of metal in the polymer-metal complex, more preferably more than 0.5%, such as more than 1.5%, most preferably more than 3.5%, such as more than 6% or more than 10% or more than 15%. Typically, the product contains less than 50%, such as less than 25%, by weight of metal in the polymer-metal complex.</p>
<p>If step (ii) is omitted, the polymer-metal complex formed in step (iii) may be in solid form. This solid can be filtered off, washed and dried. Washing may be carried out using an aqueous solution. Alternatively or subsequently, the solid S 8 polymer-metal complex may be dissolved at a pH below 6.5, using the same acids mentioned above in relation to step (ii).</p>
<p>Solutions of polymer-metal complex produced by the present invention may be treated to precipitate out the polymer-metal complex (e.g., by neutralising the solution), which can then be washed using an aqueous solution and subsequently dried. Alternatively, the solution of polymer-metal complex is spray dried to form solid polymer-metal complex in the form of a free flowing powder.</p>
<p>The polymer-metal complexes produced by the present invention may be used in sprays or aerosols, or used as a coating material, or formed into fibres, films, foams, freeze-dried mats, gels, hydrogels or sponges. In addition, the polymer-metal ion complexes may also be used as a coating material, or formed into fibres, films, solid foams, freeze-dried mats, gels, hydrogels or sponges prior to the chemical reduction step.</p>
<p>It has surprisingly been found that solutions of the polymer-metal complex produced by the process according to the invention are typically homogeneous solutions. Whereas polymer-metal ion complexes show negligible absorption across the visible spectrum, chitosan-silver complexes formed by the process as described above, in relation to the first aspect of the invention, show a strong absorption band in the region 400-420 mn. The extinction coefficient for polymer-metal complexes, measured in a 1 cm cell, based on the molar concentration of silver present, is preferably greater than 10,000 L mol' cnf'.</p>
<p>In order to improve the clarity and/or the shelf-life (stability) of the solutions produced by the process of the present invention a polymer-compatible surfactant may be added before or after steps (ii) or (iii), and before or after step (II). For example, cationic and non-ionic surfactants may be used in conjunction with chitosan and other polymers that are positively charged in solution, while anionic and non-ionic surfactants may be used in conjunction with alginate and other anionic polymers.</p>
<p>Thus, in a preferred embodiment of foe process, prior to the step of chemically reducing metal ions in the polymer-metal complex, the polymer-metal ion complex may be contacted with a surfactant, preferably, a quaternary animonium compound, such as a quaternary ammonium compound having an alkyl chain of from 6 to 24 carbon atoms, for example cetyl trimethylammonium bromide. The addition of such a compound surprisingly produces a solution which, after chemical reduction and, if required, dissolution of the polymer-metal complex, is less coloured than solutions otherwise produced.</p>
<p>Depending on the intended use, it may be desirable to insolubilise the resulting polymer-metal complex by cross-linking or other means known in the art. In order to maintain the solubility characteristics of the polymer in the resulting polymer-metal complex, preferably, no cross-linking or equivalent step is perfonned.</p>
<p>The present invention also provides a polymer-metal complex in solution, which is translucent (i.e., typically non-opalescent) and free of suspended particulate metal-containing species. This solution has unexpectedly been found to be produced by the invention. Preferably, the solution is a clear (i.e., transparent) solution.</p>
<p>The present invention also provides a solid premix. By the term solid premix, it is meant a mixture or blend of two or more components in the solid phase.</p>
<p>Preferably the premix is in the form of a powder.</p>
<p>The polymer-metal ion complex contained in the solid premix may be produced according to step (i) of the process, as described above. However, it is also contemplated that the polymer-metal ion complex may be produced according to step (I). In this latter case, the resulting solution of polymer-metal ion complex is treated to obtain the polymer-metal ion complex in the solid phase. This may be achieved using any suitable technique known in the art but is preferably performed by spray drying or a method used to induce precipitation of the solid out of solution. *1</p>
<p>The solid premix comprises a solid reducing agent. Preferably, the reducing agent is acidic, such as, for example, solid ascorbic acid or a salt thereof or mixtures thereof. Additionally, the premix may further comprise a solid acid such as glycolic acid, in addition to the polymer-metal ion complex and reducing agent.</p>
<p>S Since ascorbic acid acts as a reducing agent and aids the dissolution of certain polymer substrates (e.g., chitosan), the use of a solid acid in addition to the polymer-metal ion complex may be omitted if ascorbic acid is used as the reducing agent. It will be appreciated that if ascorbic acid is used as both a reducing agent and solubilising agent, the ascorbic acid is preferably present in a higher concentration than if it were acting solely as a reducing agent.</p>
<p>One advantage of forming a premix that is solid is the ease with which it can be transported and handled. By subsequently dissolving the solid premix, the metal ions in the polymer-metal complex can be reduced, when required. Another advantage is the greater storage life of the product in premix form compared with the storage life of the product in solution form. Also, providing the product in premix form provides greater versatility as the user may readily produce solutions of varying concentrations from the same batch of solid premix.</p>
<p>According to the process of the fifth aspect of the present invention, steps (b) and (c) may be carried out simultaneously. Therefore, the process may comprise, after step (a), contacting the product formed in (a) with an agent, such as calcium ascorbate, that causes both gelling and chemical reduction to take place.</p>
<p>Alternatively, steps (b) and (c) may be carried out sequentially and in either order, i.e., step (b) may be carried out before step (c) or, alternatively, step (c) may be carned out before step (b).</p>
<p>Suitable salts of alginic acid include sodium, calcium, potassium, magnesium and mixtures thereof. Preferably, sodium alginate is used in step (a).</p>
<p>The gelling agent used in step (b) preferably comprises calcium ions. Suitable gelling agents used in step (b) preferably include any water-soluble salt of calcium, such as calcium ascorbate.</p>
<p>The aqueous solution compri sing one or more metal salts in step (a) may be selected from the salts of any metal but are preferably selected from the salts of silver, copper, gold, palladium, platinum and tin, and mixtures thereof.</p>
<p>During step (a), metal ions are adsorbed, complexed or otherwise associated onto the alginic acid or salt thereof and/or the polyvinylamine to form an alginate/polyvinylamine-metal ion complex as described above in relation to step (i).</p>
<p>Chemical reduction of metal ions in the gel may be carried using any suitable reducing agent; however, the use of a reductone is preferred, in particular ascorbic acid or a salt thereof.</p>
<p>The present invention also provides the use of a reductone for reducing a polymer-metal ion complex to a polymer-metal complex. Preferably, the metal ions are reduced to metal atoms. In the preferred embodiment, the reductone is preferably ascorbic acid or a salt thereof. It will be appreciated that the use of a reductone for reducing polymer-metal ions can be carried out as described above in relation to step (iii), step (II) or step (c) of the processes contemplated by the present invention.</p>
<p>The products prepared by the processes of the present invention may be used as bioactive materials, particularly in the biomedical and/or healthcare fields. Also, due to the extremely reactive nature of the metal in the polymer-metal complexes these products can be used as catalysts in a number of chemical and/or biochemical processes.</p>
<p>Examples</p>
<p>Example I</p>
<p>g of finely ground chitosan particles was stirred in 70 ml deionised water. 0.6 g AgNO3 in 5 ml deionised water was added drop wise into the chitosan *1 suspension. The chitosan suspension was stirred until the supernataiit did not give any precipitate on addition to a solution of NaCI. The suspension was then diluted to 970 ml with deiomsed water and 9 ml lactic acid (80%) was added to solubilise the chitosan/Ag complex. Once a homogeneous solution was obtained a solution of 0.9 g ascorbic acid in 20 ml deionised water was added. A strong yellow-brown colour developed rapidly and full reduction was achieved within I hour.</p>
<p>Example 2</p>
<p>10 g of finely ground chitosan particles was stirred in 70 ml deionised water while 0.6 g AgNO3 in 5 ml deionised water was added drop wise to it. The suspension was stirred until the supernatant did not give any precipitate on addition to a solution of N'aCl. The suspension was diluted by the addition of 30 ml deionised water and stirred while 1 g sodium ascorbate in 25 ml deionised water was added.</p>
<p>The particles of chitosan rapidly acquired a dark brown colour indicating that the silver ions had been reduced and after 1 hour the suspension was filtered. The solid cbitosan/Ag was washed with deiorused water and dried at 60 C. A solution of 1 g of the dry powder in 100 ml of 0.9% lactic acid (80%) gave an extinction coefficient of 10,600 L mol' cnf' for the chitosan/Ag complex, based on the molar concentration of silver present.</p>
<p>Example 3</p>
<p>g of finely ground chitosan particles was stirred in 70 ml deionised water while 0.6 g AgNO3 inS ml deionised water was added drop wise to it. Stirring continued until the supernatant did not give any precipitate on addition to a solution of NaC1.</p>
<p>The suspension was then diluted to 800 ml with deionised water, and 1 6g ascorbic acid dissolved in 200 ml dcjonised water added. Reduction and solubilisation occurred concurrently to give a strongly coloured (yellow-brown) solution with an extinction coefcient> 10,000 L moF' cm', based on the molar concentration of silver present.</p>
<p>Example 4 p 3</p>
<p>g of fmely ground chitosan particles was stirred in 70 ml deionised water while 0.6 g AgNO3 in 5 ml deionised water was added drop wise to it. Stirring continued until the supernatant did not give any precipitate on addition to a solution of NaCI. The suspension was filtered and the recovered solids dried at 65 C. The dried powder was intimately blended with glycolic acid powder (7 g) and ascorbic acid powder (1 g). 43 g of the powder was weighed out into a beaker, 250 ml deionised water added and the mixture rapidly stirred. Reduction and solubilisation occurred concurrently to give a strongly coloured (yellow-brown) solution with an extinction coefficient> 10,000 L maY' cm', based on the molar concentration of silver present.</p>
<p>Example 5</p>
<p>A 10 g sample of finely ground chitosan particles was stirred in 70 ml deionised water while 0.6 g AgNO3 in 5 ml deionised water was added drop wise to it.</p>
<p>Stirring continued until the supematant did not give any precipitate on addition to a solution of NaC1. The suspension was then filtered and the recovered solids dried at 65 C. The dried powder was intimately blended with ascorbic acid powder (18 g). 7 g of the powder was weighed out into a beaker, 250 ml deionised water added and the mixture rapidly stirred. Reduction and solubilisation occurred concurrently to give a strongly coloured (yellow-brown) solution with an extinction coefficient> 10,000 L moF' crnl, based on the molar concentration of silver present.</p>
<p>Example 6</p>
<p>g of finely ground chitosan particles was stirred in 70 ml deiomsed water and 1.2 g AgNO3 in 10 ml deioaised water added drop wise to it. The chitosan suspension was stined until the filtered off supernatant did not give any precipitate on addition to a solution of NaCi. The suspension was then diluted to 950 ml with deionised water and 9 ml lactic acid (80%) was added to solubilise the chitosanJAg complex. Once a homogeneous solution was obtained a solution of 1.8 g ascorbic acid in 40 ml deionised water was added. A strong yellow-brown colour developed rapidly and full reduction was achieved within 1 hour.</p>
<p>Example 7</p>
<p>S</p>
<p>g of finely ground chitosan particles was stirred in 70 ml deionised water while 0.6 g AgNO3 in 5 ml deionised water was added drop wise to it. Stirring continued until the filtered off supernatant did not give any precipitate on addition to a solution of NaCI. The suspension was diluted by the addition of 30 ml deionised water and stirred while heating to 70-75 C. On reaching the desired temperature 1 ml hydrazine (98%) was added and stirring continued at this temperature for 1 hour then the suspension was filtered, the solid chitosanlAg washed with deionjsed water and dried at 60 C. A solution of 1 g of the dry powder in 100 ml of 0.9% lactic acid (80%) gave an extinction coefficient of 10,200 L mol' cnf' for the chitosan/Ag complex, based on the molar concentration of silver present.</p>
<p>Example 8</p>
<p>A sample (5 g) of chitosanlAg powder prepared as in Example 2 was suspended with stirring in 100 ml of water. Once the particles ofchitosanlAg were thoroughly dispersed, 3 ml lactic acid (80%) was added and the mixture stirred until a viscous solution was formed. This was then transferred to a syringe and the solution extruded into the bottom of a vertical tube containing I litre of a 2% NaOH solution. The stream of polymer solution gelled and gradually rose towards the top of the tube where it was removed and rinsed in several changes of water and then dried to give a brown fibrous product.</p>
<p>Example 9</p>
<p>g of finely powdered chitin having approximately 8% D-glucosarnine residues was slurried in 80 ml de-iomsed water containing 0.3 g AgNO3 until the filtered off supernatant did not give any precipitate on addition to a solution of NaCI. A solution of 0.3 g ascorbic acid in 10 ml deionised water was added and stirring continued for 1 hour, during which time the powder developed a dark brown colour. The solid was filtered off; rinsed well and dried.</p>
<p>Example 10</p>
<p>A solution containing 0.3 g AgNO3 and 8 g sodium alginate in 200 ml deionised water was left to stand for 24 hours in the dark. Then the solution was stirred while 10 ml of a 3.5% solution of ascorbic acid was slowly added. The solution rapidly developed a grey colour, indicating that the silver had been reduced.</p>
<p>Example ii</p>
<p>The solution prepared in Example 10 above was, before reduction of the complexed silver ions, transferred to a syringe and the solution extruded into the bottom of a vertical tube containing I litre of a dilute solution of a soluble calcium salt. The stream of polymer solution gelled on contact with the calcium ions and gradually rose towards the top of the tube where it was removed. The gel was rinsed with several changes of water, immersed in a dilute solution of ascorbic acid or sodium ascorbate, and then rinsed and dried to give a grey fibrous product that from visual inspection had a uniform colour.</p>
<p>Example 12</p>
<p>The solution prepared in Example 10 above was, before reduction of the complexed silver ions, transferred to a syringe and the solution extruded into the bottom of a vertical tube containing 1 litre of a dilute solution of a soluble calcium salt and ascorbic acid or sodium ascorbate. The stream of polymer solution gelled and gradually rose towards the top of the tube where it was removed and rinsed with several changes of water and then dried to give a grey fibrous product that from visual inspection had a uniform colour. Thus, the reduction step may be combined with the coagulation/gelation step.</p>
<p>Example 13</p>
<p>A homogeneous solution of the chitosan/Ag1 complex, prepared as described in Example 1, was heated to 70-75 C and 1.0 ml hydrazine (98%) in 5 ml deionised water added, followed by a further 1.5 ml lactic acid (80%) to redissolve the precipitated chitosan-silver complex. There was a rapid development of an intense yellow-brown colour, which on cooling back to room temperature showed an extinction coefficient similar to that of the pmduct obtained in Example 1.</p>
<p>Example 14</p>
<p>To a solution of the chitosan/Ag4 complex, as prepared in Example 1, was added 5 g of a non-ionic surfactant (Tween 20) followed by 0.9 g ascorbic acid in 20 ml deionised water. The stirred solution rapidly changed from colourless to a strong reddish-brown colour, indicating that reduction had taken place. The shelf life of this solution was found to be greater than that of a solution prepared similarly but with omission of the surfactant.</p>
<p>Example 15</p>
<p>A solution containing 10 g poly(vinylamine) in 500 ml deionised water was stirred while 0.6 g AgNO3 in 10 ml deionised water was added. After standing overnight the solution was stirred while a solution of 0.9 g ascorbic acid in 20 ml deiomsed water was added. An intense yellow- brown colour rapidly developed and reduction was complete within 1 hour.</p>
<p>Example 16</p>
<p>g of finely ground chitosan particles in 100 ml deionised water was stirred while heated to 80-85 C. Once this temperature was reached 0. 6 g AgNO3 in S ml deionised water was added drop wise to the suspension and stirring continued at 80-85 C for 1-2 hours. The mixture was diluted to 980 ml with cold deionised water and 9 ml lactic acid (80%) added to solubilise the chitosan/Ag complex.</p>
<p>Once a homogeneous solution was obtained, 0.9 g ascorbic acid in 10 ml deionised water was added and stirring continued for 1 hour, by which time the solution had developed a strong reddish-brown colour. The solution gave an extinction coefficient at 400 nm, based on the molar concentration of silver present, of> 10,000 L mol' cm'.</p>
<p>Examule 17 g of finely ground chitosan particles in 100 ml deionised water was stirred while heated to 80-85 C. Once this temperature was reached 0.6 g AgNO3 in 5 ml deionised water was added drop wise to the suspension and stirring continued at 80-85 C for 1-2 hours. The suspension was then filtered and the recovered solids dried. The dried powder was intimately blended with 7 g of glycolic acid powder and ascorbic acid powder. 4.5 g of the mixed powder was weighed out into a beaker and 250 ml deiomsed water was added and the mixture stirred.</p>
<p>Solubiisation and reduction occurred concurrently to give a strongly coloured solution with an extinction coefficient at 400 nm, based on the molar concentration of silver present, of> 10,000 L moV' cm'.</p>
<p>Example 18</p>
<p>A solution of chitosan/Ag , prepared as described in Example I above, was spray dried by a conventional process and isolated as a fine, free-flowing brown powder that could be rapidly redissolved by addition of water to give a solution having similar X, and extinction coefficient values to those of the original solution.</p>
<p>Example 19</p>
<p>g of sodium carboxymethyl cellulose (DS 0.9) was slurried in 200 ml isopropyl alcohol containing 10% water while 0.3 g AgNO3 in 2.5 ml of deionised water was added drop wise. After stirring for 2 hours 0.5 g sodium ascorbate, dissolved in the minimum amount of water, was slowly run into the suspension.</p>
<p>Stirring was continued for a further hour then the grey powder was filtered off, dispersed in 500 ml water, and the mixture stirred until a homogeneous solution was obtained. *1 18</p>
<p>Example 20</p>
<p>A suspension of 10 g of finely ground chitosan particles was stirred in 70 ml delonised water while 0.6 g AgNO3 in 5 ml deionised water was added drop wise to it. Stirring was continued until the supernatant did not give any precipitate on addition to a solution of NaC1. The suspension was diluted to 470 ml with deionised water and 9 in! lactic acid (80%) was added to solubilise the chitosan/Ag' complex. Once the complex was dissolved 2.5 g solid cetyltrimethylammonium bromide was added to the well-stirred solution, followed by 0.62 g ascorbic acid in 20 ml deicrnised water. No change in the colour of the solution was observed and there was no evidence of the development of the intense brown colour characteristic of the chitosan/Ag complex. The product was isolated as a pale yellow-brown solid on raising the pH of the solution to> 10 by addition of NaOH, filtering and rinsing well with water and drying. Redissolving the recovered solid in 0.1 M lactic acid gave a clear colourless solution that had an extinction coefficient < 100 L mol' cm, based on the molar concentration of silver present. Clear, colourless transparent films could be cast from the solution, which remained stable on standing for 3 months in daylight. a</p>
Claims (1)
- <p>CLAIMS</p><p>1. A process for producing a polymer..metal complex comprising the steps of: (i) contacting a solution comprising one or more metal salts with a polymer which is capabie of interacting with the metal salt to form a polymer-metal ion complex and wherein the polymer and the polymer metal ion complex are in the solid phase, said solid phase comprising the polymer in an amount of at least 25 % by weight and/or being in the form of a power or flake; (ii) optionally dissolving the polymer-metal ion complex; and (iii) chemically reducing metal ions in the polymer-metal ion complex to form the polymer-metal complex.</p><p>2. A process according to Claim 1, wherein the polymer comprises functional groups selected from amine, carboxylic acid, carboxylate, hydroxyl, and mixtures thereof.</p><p>3. A process according to Claim 1 or Claim 2, wherein the polymer is selected from the group consisting of chitin and chitosan.</p><p>4. A process according to Claim 1 or Claim 2, wherein the polymer is selected from the group consisting of alginate, polyvinylainine, carboxymethyl cellulose and hyaluronic acid.</p><p>5. A process according to any one of Claims I to 4, wherein (i) is carned out at a temperature of 50 to 95 C.</p><p>6. A process according to any one of Claims Ito 5, wherein (i) and (ii) are independently carried out either at a temperature of 50 to 95 C or at room temperature.</p><p>7. A process according to any one of Claims I to 6, wherein the one or more metal salts are present in an aqueous solution.</p><p>8. A process according to any one of Claims I to 7, wherein the one or more metal salts are selected from salts of silver, copper, gold, palladium, platinum, tin, and mixtures thereof.</p><p>9. A process according to any one of Claims I to 8, wherein the polymer-metal ion complex is dissolved at a pFI below 6.5.</p><p>10. A process according to any one of Claims 1 to 9, wherein (iii) is carried out using a reductone.</p><p>Ii. A process according to Claim 10, wherein the reductone is ascorbic acid or a salt thereof.</p><p>12. A process according to any one of Claims I to 11, wherein prior to (iii) the polymer metal ion complex is contacted with a quatemary ammonium compound.</p><p>13. Product obtainable by the process of any one of Claims 1 to 12.</p><p>14, Polymer-metal complex in solution, which is translucent and free of suspended particulate metal-containing species.</p><p>15. A solid premix comprising a polymer-metal ion complex and a solid reducing agent.</p><p>16. A solid premix according to Claim 15, wherein the reducing agent is acidic.</p><p>17. A solid premix according to Claim 15 or Claim 16, wherein the premix further comprises an acid.</p><p>18. A process for the production of a polymer-metal complex comprising the steps of: (a) contacting an aqueous solution comprising one or more metal salts with a solution comprising alginic acid or a salt thereof, polyvinylamine or a mixture thereof; (b) treating the solution in (a) with a gelling agent to form a gel; and (c) chemically reducing metal ions in the gel to metal atoms, wherein (b) and (c) may be carried out simultaneously or sequentially in any order.</p><p>19. A process according to Claim 18, wherein the gelling agent is a water soluble salt of calcium.</p><p>20. A process according to Claim 18 or Claim 19, wherein (b) and (c) are carried out simultaneously.</p><p>21. A process according to any one of Claims 18 to 20, wherein the one or more metal salts are selected from salts of silver, copper, gold, palladium, platinum, tin, and mixtures thereof.</p><p>22. A process according to any one of Claims 18 to 21, wherein (c) is carried out using a reductone.</p><p>23. A process according to Claim 22, wherein the reductone is ascorbic acid or a salt thereof 24. The use of a reductone for reducing a polymer-metal ion complex to a polymer-metal complex.</p>
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0614613A GB2440332A (en) | 2006-07-22 | 2006-07-22 | Polymer-metal complexes |
PCT/GB2007/002773 WO2008012514A1 (en) | 2006-07-22 | 2007-07-20 | Process |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0614613A GB2440332A (en) | 2006-07-22 | 2006-07-22 | Polymer-metal complexes |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0614613D0 GB0614613D0 (en) | 2006-08-30 |
GB2440332A true GB2440332A (en) | 2008-01-30 |
Family
ID=36998572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0614613A Withdrawn GB2440332A (en) | 2006-07-22 | 2006-07-22 | Polymer-metal complexes |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB2440332A (en) |
WO (1) | WO2008012514A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101812138A (en) * | 2010-04-27 | 2010-08-25 | 哈尔滨工业大学 | Preparation method of modified chitosan copper coordination compound and application thereof |
ITUD20100184A1 (en) * | 2010-10-11 | 2012-04-12 | Labio Test S R L | FILTER AND PROCEDURE FOR ITS REALIZATION |
CN102358787B (en) * | 2009-08-11 | 2013-06-05 | 聊城大学 | Solid phase synthesis method of silver and chitosan and/or chitosan derivative nanometer compound |
EP2647649A1 (en) * | 2012-04-04 | 2013-10-09 | Andreas Witt | Hyaluronic acid gel, method for producing the hyaluronic acid gel and medical product with the hyaluronic acid gel |
GB2597445A (en) * | 2020-07-21 | 2022-02-02 | Hydrodyne Systems Ltd | An antimicrobial cosmetic preparation |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2906444T3 (en) * | 2015-10-12 | 2022-04-18 | Reflow Medical Inc | Endoprostheses (stents) with drug delivery characteristics and associated systems. |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000049219A1 (en) * | 1999-02-20 | 2000-08-24 | Foxwood Research Limited | Substrates with biocidal properties and process for making them |
WO2002015698A1 (en) * | 2000-08-22 | 2002-02-28 | Alan John Taylor | Preparation of articles having a contact biocidal property |
EP1312262A1 (en) * | 2001-11-08 | 2003-05-21 | Alan John Taylor | Powders having contact biocidal properties |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100532695B1 (en) * | 2003-03-14 | 2005-11-30 | 한국화학연구원 | Method for making super-fine metal particle solution with high concentration |
-
2006
- 2006-07-22 GB GB0614613A patent/GB2440332A/en not_active Withdrawn
-
2007
- 2007-07-20 WO PCT/GB2007/002773 patent/WO2008012514A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000049219A1 (en) * | 1999-02-20 | 2000-08-24 | Foxwood Research Limited | Substrates with biocidal properties and process for making them |
WO2002015698A1 (en) * | 2000-08-22 | 2002-02-28 | Alan John Taylor | Preparation of articles having a contact biocidal property |
EP1312262A1 (en) * | 2001-11-08 | 2003-05-21 | Alan John Taylor | Powders having contact biocidal properties |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102358787B (en) * | 2009-08-11 | 2013-06-05 | 聊城大学 | Solid phase synthesis method of silver and chitosan and/or chitosan derivative nanometer compound |
CN101812138A (en) * | 2010-04-27 | 2010-08-25 | 哈尔滨工业大学 | Preparation method of modified chitosan copper coordination compound and application thereof |
ITUD20100184A1 (en) * | 2010-10-11 | 2012-04-12 | Labio Test S R L | FILTER AND PROCEDURE FOR ITS REALIZATION |
WO2012049551A1 (en) | 2010-10-11 | 2012-04-19 | Labio Test Srl | Filter and method for its production |
EP2647649A1 (en) * | 2012-04-04 | 2013-10-09 | Andreas Witt | Hyaluronic acid gel, method for producing the hyaluronic acid gel and medical product with the hyaluronic acid gel |
GB2597445A (en) * | 2020-07-21 | 2022-02-02 | Hydrodyne Systems Ltd | An antimicrobial cosmetic preparation |
GB2597445B (en) * | 2020-07-21 | 2022-11-09 | Hydrodyne Systems Ltd | An Antimicrobial Cosmetic Preparation |
Also Published As
Publication number | Publication date |
---|---|
WO2008012514A1 (en) | 2008-01-31 |
GB0614613D0 (en) | 2006-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Emam et al. | Polysaccharides templates for assembly of nanosilver | |
El-Rafie et al. | Environmental synthesis of silver nanoparticles using hydroxypropyl starch and their characterization | |
Abdulhameed et al. | Synthesis of chitosan-ethylene glycol diglycidyl ether/TiO2 nanoparticles for adsorption of reactive orange 16 dye using a response surface methodology approach | |
Zhao et al. | Microwave-assisted synthesis of silver nanoparticles using sodium alginate and their antibacterial activity | |
Rhazi et al. | Contribution to the study of the complexation of copper by chitosan and oligomers | |
GB2440332A (en) | Polymer-metal complexes | |
US20110129536A1 (en) | Nanocomposite materials based on metallic nanoparticles stabilized with branched polysaccharides | |
Lesnichaya et al. | Chiroplasmonic magnetic gold nanocomposites produced by one-step aqueous method using κ-carrageenan | |
Tang et al. | Mild synthesis of copper nanoparticles with enhanced oxidative stability and their application in antibacterial films | |
Varaprasad et al. | Development of high alginate comprised hydrogels for removal of Pb (II) ions | |
CN102604115B (en) | Carboxymethyl chitosan quaternary ammonium salt/PAMAM(Polyamidoamine) core-shell nanoparticles and preparation method | |
Huang et al. | Effect of quaternization degree on physiochemical and biological activities of chitosan from squid pens | |
Monti et al. | Structure and dynamics of gold nanoparticles decorated with chitosan–gentamicin conjugates: ReaxFF molecular dynamics simulations to disclose drug delivery | |
El-Sheikh et al. | Green synthesis of hydroxyethyl cellulose‐stabilized silver nanoparticles | |
CN106146913A (en) | Chitosan-based hydrogel and preparation method and application thereof | |
JP2011511885A (en) | Method for producing noble metal nanoparticle dispersion and method for isolating such nanoparticles from said dispersion | |
Al-Muhanna et al. | Preparation of stable sols of silver nanoparticles in aqueous pectin solutions and properties of the sols | |
Cheviron et al. | Starch/silver nanocomposite: Effect of thermal treatment temperature on the morphology, oxygen and water transport properties | |
Zheng et al. | In situ generation of silver nanoparticles within crosslinked 3D guar gum networks for catalytic reduction | |
El-Sherif et al. | Hydrogels as template nanoreactors for silver nanoparticles formation and their antimicrobial activities | |
Kaur et al. | A review on grafted, crosslinked and composites of biopolymer Xanthan gum for phasing out synthetic dyes and toxic metal ions from aqueous solutions | |
Tay et al. | A facile approach for controlled synthesis of hydrophilic starch‐based nanoparticles from native sago starch | |
Lv et al. | Preparation of dialdehyde chitosan and its application in green synthesis of silver nanoparticles | |
Hon et al. | Chelation of chitosan derivatives with zinc ions. I. O, N‐carboxymethyl chitosan | |
Du et al. | Synthesis of ferrocene/chitosan-AgNPs films and application in plasmonic color-switching and antimicrobial materials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |